Your session is about to expire
← Back to Search
Platelet-Rich Plasma for Tendinopathy
N/A
Recruiting
Led By Felix Gonzalez, MD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 6, month 9, month 12
Awards & highlights
Study Summary
This trial will use real-time ultrasound to study the difference between healthy and unhealthy Achilles tendons, as well as the degree of healing after minimally invasive surgery and injections of Platelet-Rich Plasma.
Eligible Conditions
- Tendinopathy
- Achilles Tendinopathy
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ month 6, month 9, month 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 6, month 9, month 12
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in The Foot & Ankle Disability Index (FADI) Score
Change in The Foot & Ankle Disability Index (FADI) Sport Score
Change in Victorian Institute of Sport Assessment - Achilles (VISA-A) Score
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Platelet-Rich PlasmaExperimental Treatment1 Intervention
Participants with moderate to severe tendinosis receiving ultrasound-guided percutaneous tenotomy with an injection of Platelet-Rich Plasma (PRP) to treat chronic tendinopathy
Find a Location
Who is running the clinical trial?
Emory UniversityLead Sponsor
1,636 Previous Clinical Trials
2,560,498 Total Patients Enrolled
2 Trials studying Tendinopathy
194 Patients Enrolled for Tendinopathy
Felix Gonzalez, MDPrincipal InvestigatorEmory University
David Reiter, PhDPrincipal InvestigatorEmory University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have been diagnosed with tendon injury using ultrasound.You have pain in your lower legs, but not in the tendons.You have been diagnosed with tendon pain and are seeking treatment at the study location.
Research Study Groups:
This trial has the following groups:- Group 1: Platelet-Rich Plasma
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger